Breaking News
0

Gilead Sciences Inc (GILD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Gilead's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
67.49 -0.66    -0.97%
16:00:06 - Closed. Currency in USD ( Disclaimer )
After Hours
67.49
0.00
0.00%
16:05:34 - Real-time Data
Type: Equity
Market: United States
ISIN: US3755581036 
CUSIP: 375558103
  • Volume: 8,623,573
  • Bid/Ask: 67.00 / 67.49
  • Day's Range: 65.92 - 69.87
Gilead 67.49 -0.66 -0.97%

GILD Dividends

 
Get information about Gilead dividends and ex-dividend dates. You can find more details by going to one of the sections under this page such as ex-date, dividend and payment date.
Ex-Dividend Date Dividend Type Payment Date Yield
Dec 13, 2018 0.57 Dec 28, 2018 3.25%
Sep 13, 2018 0.57 Sep 27, 2018 3.18%
Jun 14, 2018 0.57 Jun 28, 2018 2.95%
Mar 15, 2018 0.57 Mar 29, 2018 3.16%
Dec 14, 2017 0.52 Dec 28, 2017 2.55%
Sep 14, 2017 0.52 Sep 28, 2017 2.60%
Show more
Legend
Monthly
Quarterly
Semi-Annual
Annual
Trailing Twelve Months
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GILD Comments

Write your thoughts about Gilead Sciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Padraig Crowley
Padraig Crowley Jul 06, 2018 4:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
am short GILD from $67 - anyone else think that the price will go lower than that at some stage over the summer?
Reply
0 3
태범 김
태범 김 Jul 06, 2018 4:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
No. The company is poised for a major breakout upwards. It has positioned itself a leader in cell therapy with Kite Pharma acquisition, and has a strong base in the HIV market which is a huge cash cow, and still maintains considerable presence in Hepatitis B, C markets. . . While Hepatitis C market is bound to shrink, the company's anti-viral platform is not something that's to be looked over. . . Also coming out are NASH treatment regiments which if approved will be HUGE. . . There are some ifs to a bull case, but we all know that we have to place our bets in the defining moments.
Reply
2 0
yusuf zubir
yusuf zubir Jan 27, 2018 8:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any comment on earning? Momentum?
Reply
0 0
Sal Monella
Sal Monella Nov 16, 2017 6:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Typical WALL STREET fraud & theft! Company beats earnings estimates for 4 consecutive quarters TOP to BOTTOM & they crash the stock by 15% in following 3-4 weeks, after KITE acquisition & positive FDA Nescarta data. Even that greedy ***of a fraudster Jim Cramer was still telling people to sell in the low 70s. Please God. Next time, put Cramer in that bike path for the next lone wolf to run over.
Reply
0 4
Episcopolian OptionTrader
Episcopolian1 Oct 02, 2017 1:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$GILD The NASH Phase 2 data release iis now delayed until end-of-the-yea, possibly 1st qtr of 2018. Not good! but very good sign for $ICPT
Reply
0 0
Episcopolian OptionTrader
Episcopolian1 Oct 02, 2017 1:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sell $GILD and buy $ICPT
Reply
0 0
Episcopolian OptionTrader
Episcopolian1 Sep 28, 2017 10:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Floor chatter about Phase 2 NASH has failed!
Reply
0 0
Episcopolian OptionTrader
Episcopolian1 Sep 28, 2017 10:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
A bad feeling about $GILD's COO retirement announcement, right before NASH announcement!!!
Reply
0 0
Episcopolian OptionTrader
Episcopolian1 Mar 17, 2017 9:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Price target raised to $110
Reply
0 0
Episcopolian OptionTrader
Episcopolian1 Mar 10, 2017 9:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
GILD is about to announce a huge acquisition. Buy it before that happens. $100 price target!.
Reply
0 0
Danny Alasha
Danny Alasha Dec 30, 2016 12:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good job pop star, I see head and shoulders here but despite, 2017 pick
Reply
0 0
Nov 01, 2016 9:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I like what I see
Reply
0 0
Nov 01, 2016 9:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
That's right!:)
Reply
0 0
Pop Star
Pop Star Aug 19, 2016 5:36PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Headed to 86 in two weeks
Reply
0 0
Jeffrey Wright
Jeffrey Wright Apr 16, 2016 8:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Even after having to pay merk 200m?
Reply
0 0
David Simpson
David Simpson Feb 29, 2016 12:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What a bargain at these levels.....buy buy buy.
Reply
0 0
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email